Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1531 AL 1545

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Siafarikas N, Kirsebom BE, Srivastava DP, Eriksson CM, Auning E, Hessen E, Selbaek G, Blennow K, Aarsland D, Fladby T.

Sci Rep. 2021 Oct 13;11(1):20375. doi: 10.1038/s41598-021-99794-9.

Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum

Benedet AL, Milà-Alomà M, Vrillon A, Ashton NJ, Pascoal TA, Lussier F, Karikari TK, Hourregue C, Cognat E, Dumurgier J, Stevenson J, Rahmouni N, Pallen V, Poltronetti NM, Salvadó G, Shekari M, Operto G, Gispert JD, Minguillon C, Fauria K, Kollmorgen G, Suridjan I, Zimmer ER, Zetterberg H, Molinuevo JL, Paquet C, Rosa-Neto P, Blennow K, Suárez-Calvet M; Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer’s and Families (ALFA) study, and BioCogBank Paris Lariboisière cohort.

JAMA Neurol. 2021 Dec 1;78(12):1471-1483. doi: 10.1001/jamaneurol.2021.3671.

Crosstalk between epigenetics and mTOR as a gateway to new insights in pathophysiology and treatment of Alzheimer's disease

Agarwal D, Kumari R, Ilyas A, Tyagi S, Kumar R, Poddar NK.

Int J Biol Macromol. 2021 Dec 1;192:895-903. doi: 10.1016/j.ijbiomac.2021.10.026. Epub 2021 Oct 15.

Current research status of blood biomarkers in Alzheimer's disease: Diagnosis and prognosis

Feng L, Li J, Zhang R.

Ageing Res Rev. 2021 Dec;72:101492. doi: 10.1016/j.arr.2021.101492. Epub 2021 Oct 19.

Non-Ceruloplasmin Copper as a Stratification Biomarker of Alzheimer's Disease Patients: How to Measure and Use It

Squitti R, Ventriglia M, Granzotto A, Sensi SL, Rongioletti MCA.

Curr Alzheimer Res. 2021;18(7):533-545. doi: 10.2174/1567205018666211022085755.

A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach

Tan MS, Cheah PL, Chin AV, Looi LM, Chang SW.

Comput Biol Med. 2021 Dec;139:104947. doi: 10.1016/j.compbiomed.2021.104947. Epub 2021 Oct 14.

Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer's Disease

Huang YL, Lin CH, Tsai TH, Huang CH, Li JL, Chen LK, Li CH, Tsai TF, Wang PN.

Int J Mol Sci. 2021 Oct 9;22(20):10903. doi: 10.3390/ijms222010903.

Alzheimer's disease associated with Down syndrome: a genetic form of dementia

Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M.

Lancet Neurol. 2021 Nov;20(11):930-942. doi: 10.1016/S1474-4422(21)00245-3.

Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review

Jeremic D, Jiménez-Díaz L, Navarro-López JD.

Ageing Res Rev. 2021 Dec;72:101496. doi: 10.1016/j.arr.2021.101496. Epub 2021 Oct 21.

The prognostic utility of CSF neurogranin in predicting future cognitive decline in the Alzheimer's disease continuum: A systematic review and meta-analysis with narrative synthesis

Yoong SQ, Lu J, Xing H, Gyanwali B, Tan YQ, Wu XV.

Ageing Res Rev. 2021 Dec;72:101491. doi: 10.1016/j.arr.2021.101491. Epub 2021 Oct 21.

Association of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: New Entity or Coincidence? A Case Series

Vrillon A, Deramecourt V, Pasquier F, Magnin É, Wallon D, Lozeron P, Bouaziz-Amar É, Paquet C.

J Alzheimers Dis. 2021;84(4):1439-1446. doi: 10.3233/JAD-215226.

Cerebrospinal Fluid Biomarker Levels as Markers for Nursing Home Placement and Survival Time in Alzheimer's Disease

Wattmo C, Blennow K, Hansson O.

Curr Alzheimer Res. 2021;18(7):573-584. doi: 10.2174/1567205018666211022164952.

Amyloid and Tau in Alzheimer's Disease: Biomarkers or Molecular Targets for Therapy? Are We Shooting the Messenger?

Kumar A, Nemeroff CB, Cooper JJ, Widge A, Rodriguez C, Carpenter L, McDonald WM.

Am J Psychiatry. 2021 Nov;178(11):1014-1025. doi: 10.1176/appi.ajp.2021.19080873.

A Review of Methods of Diagnosis and Complexity Analysis of Alzheimer's Disease Using EEG Signals

Ouchani M, Gharibzadeh S, Jamshidi M, Amini M.

Biomed Res Int. 2021 Oct 27;2021:5425569. doi: 10.1155/2021/5425569. eCollection 2021.

Effects of exosomal miRNAs in the diagnosis and treatment of Alzheimer's disease

Cui GH, Zhu J, Wang YC, Wu J, Liu JR, Guo HD.

Mech Ageing Dev. 2021 Dec;200:111593. doi: 10.1016/j.mad.2021.111593. Epub 2021 Oct 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias